BCL2L2 and hepatocellular carcinoma: The expression of all four genes tended to be increased in miR-24-3p silenced HCC cells (Fig. S5A), but only cells overexpressing Bcl-2 like 2 (BCL2L2) exhibited a better cell viability after exposure to Lenvatinib compared to the other three genes (Fig. S5B-C).